Université Bourgogne Franche-Comté - INSERM UMR 1231, CHU Dijon Bourgogne, Laboratoire de Biologie de la Reproduction - CECOS, Dijon, France.
Unilabs, direction médicale, Clichy-La-Garenne, France.
Hum Reprod. 2021 Feb 18;36(3):808-816. doi: 10.1093/humrep/deaa323.
STUDY QUESTION: Do IVF, IUI or female infertility (i.e. endometriosis, polycystic ovary syndrome [PCOS] and primary ovarian insufficiency [POI]) lead to an increased risk of congenital anomalies in singletons? SUMMARY ANSWER: After multivariable adjustments, the increased risks of congenital defects associated with IUI were no longer significant, but the underlying maternal infertility presented a potential emental risk, in addition to the risk associated with IVF. WHAT IS KNOWN ALREADY: Most epidemiological studies suggest that singletons born from ART have a higher risk of birth defects, specifically musculoskeletal, cardiovascular and urogenital disorders. However, most of these studies were established on data obtained at birth or in the neonatal period and from relatively small populations or several registries. Moreover, to our knowledge, female infertility, which is a potential confounder, has never been included in the risk assessment. STUDY DESIGN, SIZE, DURATION: Using data from the French National Health System database, we conducted a comparative analysis of all singleton births (deliveries ≥22 weeks of gestation and/or >500 g of birthweight) in France over a 5-year period (2013-2017) resulting from fresh embryo or frozen embryo transfer (fresh-ET or FET from IVF/ICSI cycles), IUI and natural conception (NC). Data were available for this cohort of children at least up to early childhood (2.5 years old). PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 3 501 495 singleton births were included (3 417 089 from NC, 20 218 from IUI, 45 303 from fresh-ET and 18 885 from FET). Data were extracted from national health databases and used to identify major birth defects. Malformations were classified according to the 10th revision of the International Classification of Disease. To analyse the effect of mode of conception, multivariable analyses were performed with multiple logistic regression models adjusted for maternal age, primiparity, obesity, smoking, history of high blood pressure or diabetes and female infertility. MAIN RESULTS AND THE ROLE OF CHANCE: In our cohort of children, the overall prevalence of congenital malformations was 3.78% after NC, 4.53% after fresh-ET, 4.39% after FET and 3.91% after IUI (132 646 children with major malformations). Compared with infants conceived naturally, children born after fresh-ET and after FET had a significantly higher prevalence of malformations, with an adjusted odds ratio (aOR) of 1.15 [95% CI 1.10-1.20, P < 0.0001] and aOR of 1.13 [95% CI 1.05-1.21, P = 0.001], respectively. Among the 15 relevant subgroups of malformations studied, we observed a significantly increased risk of eight malformations in the fresh-ET group compared with the NC group (i.e. musculoskeletal, cardiac, urinary, digestive, neurological, cleft lip and/or palate and respiratory). In the FET group, this increased risk was observed for digestive and facial malformations. The overall risk of congenital malformations, and the risk by subtype, was similar in the IUI group and the NC group (overall risk: aOR of 1.01 [95% CI 0.94-1.08, P = 0.81]). In addition, there was an overall independent increase in the risk of congenital defects when the mothers were diagnosed with endometriosis (1.16 aOR [95% CI 1.10-1.22], P < 0.0001), PCOS (1.20 aOR [95% CI 1.08-1.34], P = 0.001) or POI (1.52 aOR [95% CI 1.23-1.88], P = 0.0001). Chromosomal, cardiac and neurological anomalies were more common in the three maternal infertility groups. LIMITATIONS, REASONS FOR CAUTION: Male infertility, the in vitro fertilization method (i.e. in vitro fertilization without or with sperm injection: conventional IVF vs ICSI) and embryo stage at transfer could not be taken into account. Furthermore, residual confounding cannot be excluded as well as uncertainties regarding the diagnostic criteria used for the three female infertilities. Findings for specific malformations should be interpreted with caution because the number of cases was small in some sub-groups (potentially due to the Type I error or multiple testing). WIDER IMPLICATIONS OF THE FINDINGS: In this large study, after multivariable maternal adjustments, a moderately increased risk of defects subsisted after IVF, while those associated with IUI were no longer significant. In addition, our results showed that underlying maternal infertility could contribute to the increased risk of defects associated with IVF. These novel findings highlight the importance of taking into account the ART treatment methods and the type of infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Agency of Biomedicine. The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: NA.
研究问题:体外受精(IVF)、宫腔内人工授精(IUI)或女性不孕(如子宫内膜异位症、多囊卵巢综合征[PCOS]和卵巢早衰[POI])是否会增加单胎的先天性畸形风险?
总结答案:经过多变量调整后,与 IUI 相关的先天性缺陷风险不再显著,但潜在的母体不孕是除了与 IVF 相关的风险之外的一个潜在的根本风险。
已知情况:大多数流行病学研究表明,ART 出生的单胎婴儿更有可能出现出生缺陷,特别是肌肉骨骼、心血管和泌尿生殖系统疾病。然而,这些研究大多基于出生或新生儿期的数据,并且来自相对较小的人群或多个登记处。此外,据我们所知,女性不孕,这是一个潜在的混杂因素,从未被纳入风险评估中。
研究设计、大小、持续时间:本研究使用法国国家卫生系统数据库的数据,对法国 5 年内(2013-2017 年)所有单胎活产(妊娠 22 周以上且/或出生体重>500 克)进行了比较分析,包括新鲜胚胎或冷冻胚胎移植(来自 IVF/ICSI 周期的新鲜胚胎转移[FET]或体外受精[IVF])、IUI 和自然受孕(NC)。至少在幼儿期(2.5 岁)之前,该队列的儿童数据都可用。
参与者/材料、设置、方法:共纳入 3501495 例单胎活产(3417089 例来自 NC,20218 例来自 IUI,45303 例来自新鲜胚胎转移,18885 例来自 FET)。数据从国家卫生数据库中提取并用于识别主要的先天性畸形。畸形根据国际疾病分类第 10 次修订版进行分类。为了分析受孕方式的影响,使用多变量逻辑回归模型进行了多变量分析,调整了母亲年龄、初产、肥胖、吸烟、高血压或糖尿病史以及女性不孕。
主要结果和机遇的作用:在我们的儿童队列中,NC 后先天性畸形的总体患病率为 3.78%,FET 后为 4.39%,FET 后为 4.53%,IUI 后为 3.91%(132646 例主要畸形儿童)。与自然受孕的婴儿相比,FET 和 FET 后出生的婴儿畸形患病率明显更高,调整后的优势比(aOR)分别为 1.15[95%CI 1.10-1.20,P<0.0001]和 1.13[95%CI 1.05-1.21,P=0.001]。在研究的 15 个相关畸形亚组中,我们观察到 FET 组与 NC 组相比,8 种畸形的风险显著增加(即肌肉骨骼、心脏、泌尿、消化、神经、唇裂和/或腭裂和呼吸系统)。在 FET 组中,这种风险增加发生在消化和面部畸形中。IUI 组和 NC 组的先天性畸形总体风险和亚型风险相似(总体风险:aOR 为 1.01[95%CI 0.94-1.08,P=0.81])。此外,当母亲被诊断为子宫内膜异位症(1.16 aOR[95%CI 1.10-1.22],P<0.0001)、多囊卵巢综合征(1.20 aOR[95%CI 1.08-1.34],P=0.001)或卵巢早衰(1.52 aOR[95%CI 1.23-1.88],P=0.0001)时,先天性缺陷的总体风险也会增加。染色体、心脏和神经系统异常在这三种母体不孕组中更为常见。
局限性、谨慎的原因:男性不育、体外受精方法(即无精子注射或精子注射:常规 IVF 与 ICSI)和胚胎转移阶段都无法考虑在内。此外,由于存在残余混杂因素以及对三种女性不育症使用的诊断标准存在不确定性,因此不能排除不确定性。由于某些亚组中的病例数量较少(可能是由于 I 型错误或多次测试),因此对特定畸形的发现应谨慎解释。
研究结果的更广泛意义:在这项大型研究中,经过多变量母亲调整后,IVF 后仍存在中度缺陷风险,而与 IUI 相关的风险不再显著。此外,我们的研究结果表明,潜在的母体不孕可能导致与 IVF 相关的缺陷风险增加。这些新发现强调了在考虑 ART 治疗方法和不孕类型时应考虑到这些因素。
研究资金/利益冲突:这项工作得到了国家生物医学机构的支持。作者没有利益冲突需要披露。
试验注册编号:无。
Curr Oncol. 2022-8-15